Research Article

Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells

Volume: 55 Number: 3 January 14, 2026

Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells

Abstract

Background and Aims: Myrtle (Myrtus communis L.) has been used as a food and folk medicine since ancient times. The aim of this study was to determine the antioxidant capacity, inhibition of tyrosinase enzyme, and cytotoxicity of 12 extracts from the fruit, seed, leaves, and twigs of Myrtus communis L. subsp. communis. Methods: The cytotoxic effects on human lung (A549), liver (Hep3B), prostate (PC-3) and breast (MCF7) cancer cells and healthy L929 cells were determined using the MTT method. Tyrosinase enzyme inhibition was investigated using L-tyrosine as the substrate. The antioxidant capacity was determined using the DPPH, TEAC and CUPRAC methods. Results: It was found that the extracts did not affect the viability of healthy cells but showed concentration- dependent toxic effects on cancer cells. The ethyl acetate sub-extracts of the plant parts showed a higher cytotoxic effect on all cell lines, and the ethyl acetate sub-extract of the seed was the most effective with 72.6% proliferation inhibition against the Hep3B. The methanol extract and ethyl acetate sub-extract of the seed showed the highest inhibition against tyrosinase and the values were 388.6 and 412.8 mg KAE/g extract, respectively. While all extracts showed significant antioxidant activities in all methods, the ethyl acetate sub-extract of seeds showed the highest. Conclusion: This is the first comparative study to investigate the antiproliferative effects of extracts from various parts of Myrtus communis L. subsp. communis. The results show that seeds in particular can be a promising, effective and recyclable resource that can be safely used in the pharmaceutical and cosmetic industries.

Keywords

References

  1. Al-Najjar, B. O., Elshibani, F., Sharkasi, M. A., Shintiri, N. E., Naili, E. E., Abdulsayid, M., Abozayed, R. S., & Mohammed, H. A. (2025). Phytochemical analysis, bioactivity, and molecular docking studies of Myrtus communis L. seeds and fruit peel extracts demonstrating antioxidant and anti-tyrosinase properties. Scientific Reports, 15(1), 5634. google scholar
  2. Al-Snafi, A. E., Teibo, J. O., Shaheen, H. M., Akinfe, O. A., Teibo, T. K. A., Emieseimokumo, N., Elfiky, M. M., Al-Kuraishy, H. M., Al-Garbeeb, A. I., & Alexiou, A. (2024). The therapeutic value of Myrtus communis L.: an updated review. Naunyn^ Schmiedeberg's Archives of Pharmacology, 397(7), 4579-4600. google scholar
  3. Alipour, G., Dashti, S., & Hosseinzadeh, H. (2014). Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytotherapy research, 28(8), 1125-1136. google scholar
  4. Apak, R., Güçlü, K., Demirata, B., Özyürek, M., Çelik, S. E., Bektaşoğlu, B., Berker, K. I., & Özyurt, D. (2007). Comparative evaluation of various total antioxidant capacity assays applied to phenolic compounds with the CUPRAC assay. Molecules, 12(7), 1496-1547. google scholar
  5. Azimi, M., & Hasheminasab, F. S. (2020). Evaluating the efficacy and safety of the myrtle (Myrtus communis) in treatment and prognosis of patients suspected to novel coronavirus disease (COVID-19): study protocol for a randomized controlled trial. Trials, 21, 1-5. google scholar
  6. Belahcene, S., Kebsa, W., Akingbade, T. V., Umar, H. I., Omoboyowa, D. A., Alshihri, A. A., Abo Mansour, A., Alhasaniah, A. H., Oraig, M. A., & Bakkour, Y. (2024). Chemical composition antioxidant and anti-inflammatory activities of Myrtus google scholar communis L. leaf extract: Forecasting ADMET profiling and anti-inflammatory targets using molecular docking tools. Molecules, 29(4), 849. google scholar
  7. Belahcene, S., Kebsa, W., Omoboyowa, D. A., Alshihri, A. A., Alelyani, M., Bakkour, Y., & Leghouchi, E. (2023). Unveiling the chemical profiling antioxidant and antiinflammatory activities of algerian Myrtus communis L. essential oils, and exploring molecular docking to predict the inhibitory compounds against cyclooxygenase-2. Pharmaceuticals, 16(10), 1343. google scholar
  8. Bilgic, N., & Duran, G. G. (2020). Chemical composition of Myrtus communis L. and Proapoptotic effects on the A549 cell line. Journal of Essential Oil Bearing Plants, 23(6), 1283-1295. google scholar

Details

Primary Language

English

Subjects

Pharmacognosy

Journal Section

Research Article

Publication Date

January 14, 2026

Submission Date

June 26, 2025

Acceptance Date

November 14, 2025

Published in Issue

Year 2025 Volume: 55 Number: 3

APA
Bayrakçeken Güven, Z., & Tugay, O. (2026). Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells. İstanbul Journal of Pharmacy, 55(3), 435-443. https://doi.org/10.26650/IstanbulJPharm.2025.1728301
AMA
1.Bayrakçeken Güven Z, Tugay O. Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells. iujp. 2026;55(3):435-443. doi:10.26650/IstanbulJPharm.2025.1728301
Chicago
Bayrakçeken Güven, Zühal, and Osman Tugay. 2026. “Myrtus Communis L. Subsp. Communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells”. İstanbul Journal of Pharmacy 55 (3): 435-43. https://doi.org/10.26650/IstanbulJPharm.2025.1728301.
EndNote
Bayrakçeken Güven Z, Tugay O (January 1, 2026) Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells. İstanbul Journal of Pharmacy 55 3 435–443.
IEEE
[1]Z. Bayrakçeken Güven and O. Tugay, “Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells”, iujp, vol. 55, no. 3, pp. 435–443, Jan. 2026, doi: 10.26650/IstanbulJPharm.2025.1728301.
ISNAD
Bayrakçeken Güven, Zühal - Tugay, Osman. “Myrtus Communis L. Subsp. Communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells”. İstanbul Journal of Pharmacy 55/3 (January 1, 2026): 435-443. https://doi.org/10.26650/IstanbulJPharm.2025.1728301.
JAMA
1.Bayrakçeken Güven Z, Tugay O. Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells. iujp. 2026;55:435–443.
MLA
Bayrakçeken Güven, Zühal, and Osman Tugay. “Myrtus Communis L. Subsp. Communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells”. İstanbul Journal of Pharmacy, vol. 55, no. 3, Jan. 2026, pp. 435-43, doi:10.26650/IstanbulJPharm.2025.1728301.
Vancouver
1.Zühal Bayrakçeken Güven, Osman Tugay. Myrtus communis L. subsp. communis Seeds Exhibit Potent Antioxidant Capacity, Enzyme Inhibition, and Selective Cytotoxicity Against Lung, Breast, Prostate, and Liver Human Cancer Cells. iujp. 2026 Jan. 1;55(3):435-43. doi:10.26650/IstanbulJPharm.2025.1728301